Skip to content

NOREVA BE

Active
Private limited companyfounded 201610 yrs activeKortrijksesteenweg 1126, 9051 Gent, BelgiumKBO/BCE: BE 0647.650.984

NOREVA BE has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €75k and a net result of €43k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 77% of 11200 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
93 / 100
Excellent▲ +38 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+59
Growth78=
Stability100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 4.13 against 1.31 in 2024), and 24.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
75.8%
Return on assets
43.1%
Age of the figures
11 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €75k
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 16-01-2026, 104 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
104 d early
2024
149 d early
2023
106 d early
2022
117 d early
2021
52 d early
2020
37 d early
2019
52 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€75k▲ 132%
2024 · €33k
2018: €-256k 2019: €-161k 2020: €-93k 2021: €-31k 2022: €4k 2023: €22k 2024: €33k
2018 → 2025
Total assets
€99k▼ 27.7%
2024 · €138k
2018: €26k 2019: €322k 2020: €291k 2021: €314k 2022: €140k 2023: €151k 2024: €138k
2018 → 2025
Net result
€43k▲ 299%
2024 · €11k
2018: €-75k 2019: €95k 2020: €69k 2021: €61k 2022: €35k 2023: €18k 2024: €11k
2018 → 2025
Working capital
€75k▲ 132%
2024 · €33k
2018: €-256k 2019: €-161k 2020: €-93k 2021: €-31k 2022: €4k 2023: €22k 2024: €33k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€-31k-€4k€22k▲ 433%€33k▲ 49.3%€75k▲ 132%
Operating result€69k-€42k▼ 38.6%€33k▼ 21.3%€23k▼ 31.0%€64k▲ 178%
Net result€61k-€35k▼ 42.7%€18k▼ 49.7%€11k▼ 39.3%€43k▲ 299%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60kOperating result 2021: €69k€69kNet result 2021: €61k€61kOperating result 2022: €42k€42kNet result 2022: €35k€35kOperating result 2023: €33k€33kNet result 2023: €18k€18kOperating result 2024: €23k€23kNet result 2024: €11k€11kOperating result 2025: €64k€64kNet result 2025: €43k€43k20212022202320242025
The operating result recovers in 2025; 2025 is 178% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €99k
Equity €75k▲ 132%
Debt €24k▼ 77.1%
The debt ratio falls from 76.3% to 24.2%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
Solvency
75.8%
2024 · 23.7%
Current ratio
4.13
2024 · 1.31
Quick ratio
2.19
2024 · 0.88
Debt / equity
0.32
2024 · 3.23
ROE
56.8%
2024 · 33.0%
ROA
43.1%
2024 · 7.8%
Debt
€24k
2024 · €105k
Debt ≤ 1 year
€24k
2024 · €105k
Income taxes
€15k
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€138k€99k
Current assets29/58€138k€99k
Stocks and contracts in progress3€45k€47k
Stocks30/36€45k€47k
Amounts receivable within one year40/41€78k€34k
Trade receivables40€40k€34k
Other amounts receivable41€39k€0
Cash at bank and in hand54/58€14k€19k
Equity and liabilities
Total equity and liabilities10/49€138k€99k
Equity10/15€33k€75k
Contributions10/11€6k€6k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€0
Reserves not available under the articles1311€2k€0
Distributable reserves133-€2k
Profit (loss) carried forward14€24k€67k
Amounts payable17/49€105k€24k
Amounts payable within one year42/48€105k€24k
Trade debts44€47k€13k
Suppliers440/4€47k€13k
Taxes, remuneration and social security45€70€11k
Taxes450/3€70€11k
Other amounts payable47/48€58k€797
Income statement Code20242025
Other operating charges640/8€629€608
Gross operating margin9900€24k€64k
Operating profit (loss)9901€23k€64k
Financial income75/76B€4€1
Recurring financial income75€4€1
Financial charges65/66B€9k€6k
Recurring financial charges65€9k€6k
Profit (loss) for the period before taxes9903€14k€58k
Income taxes67/77€4k€15k
Profit (loss) for the period9904€11k€43k
Profit (loss) for the period to be appropriated9905€11k€43k
Appropriation of the result
Profit (loss) to be appropriated9906€24k€67k
Profit (loss) brought forward from the previous period14P€14k€24k

The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
16-01
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial Liquidity triplescurrent ratio 4.13
Current ratio from 1.31 to 4.13; short-term debt falls from €105k to €24k.
2024
02-12
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
15-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
03-01
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
09-03
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
24-03
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
09-03
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
30-09
Financial Back to profitnet €95k
Net result €95k after one loss-making year.
30-04
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
27-04
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-04
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2016
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kortrijksesteenweg 11269051 Gent
Ground area
1,329 m²
Building footprint
635 m²
Volume, LiDAR
5,583 m³
Parcel 44062B0052/00Y000, Flanders · tallest building 13.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
NOREVA BE
Kortrijksesteenweg 1126, 9051 GentWholesale of pharmaceutical and medical goods
since 20162.254.582.678
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44062B0052/00Y000 Flanders 1,329 m² 1 · 635 m² 13.3 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,894 companies in sector 46460 we hold annual accounts for 1,114. 552 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded29-01-2016
Fiscal year end30-09
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.